Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 71
News
News | 22 August 2023

LEO Pharma to acquire Timber Pharmaceuticals

The deal represents a total transaction value of up to $36 million with an initial upfront consideration of $14 million

News
News | 22 August 2023

Shiva Pharmachem files DRHP for its Rs. 900 crore IPO

The offer for sale comprises of up to Rs. 383 crore by Vishal Rakesh Agrawal, up to Rs. 383 crore by Rahul Rakesh Agrawal, and up to Rs. 134 crore by Geetganga Investment

News
News | 21 August 2023

Venus Remedies launches its flagship R&D drug Elores in Oman

The antibacterial market in Oman is worth US $7.5 million, and Elores is looking to capture 0.5 per cent of this segment by year 2025

News
News | 20 August 2023

Lupin receives approval from USFDA for Bromfenac Ophthalmic

Bromfenac Ophthalmic Solution 0.09% (RLD Bromday) had estimated annual sales of USD 11 million in the U.S. (IQVIA MAT June 2023).

News
News | 19 August 2023

Lupin acquires Boehringer Ingelheim's brands Ondero and Ondero Met to expand diabetes portfolio in India

This acquisition strengthens Lupin's commitment to providing superior treatment options for patients navigating the complexities of diabetes

News
News | 18 August 2023

Honeywell, Recipharm to speed development of inhalers

Honeywell Solstice Air is a hydrofluoroolefin (HFO) propellant in clinical development today for pMDIs

News
News | 18 August 2023

BASF, Promega and Swiss TPH collaborate to drive research for malaria control

Proteolysis Targeting Chimeras (PROTACs) technology as potential new method for mosquito-borne disease control

News
News | 17 August 2023

Aurobindo to launch HIV triple combination product for children living with HIV in low and middle-income countries

Aurobindo's product is already filed with the Drugs Controller General of India (DCGI) and is expected to be approved soon

News
News | 17 August 2023

Lupin launches ‘Jeet’ to raise awareness of cardiovascular disease among patients

Jeet will be a trusted partner in cardiovascular care

News
News | 17 August 2023

Lupin Launches Tiotropium Dry Powder for Inhaler for COPD in US

Lupin actively contributes to alleviating the burden of COPD for patients across the nation

News
News | 16 August 2023

SSI Strategy to acquires NDA Group partner to form global life sciences consultancy

Combination creates an integrated provider of drug development and regulatory consulting services serving a complementary client base

News
News | 16 August 2023

Mobile addicted generation heading towards hearing disorders: Survey

The survey findings for Delhi-NCR revealed that speech sound disorders exhibit higher prevalence rates in the 6-12 years age group

News
News | 16 August 2023

Exor to buy 15% shareholding in Philips

Exor’s investment in Philips will not result in any share dilution and has been carried out by way of on-market share purchases

News
News | 13 August 2023

Aurobindo Pharma reports Q1 FY24 consolidated PAT at Rs. 570.75 Cr

Aurobindo Pharma has reported total income of Rs. 6966.85 crores during the period ended June 30, 2023

News
News | 13 August 2023

Krsnaa Diagnostics posts Q1 FY24 consolidated PAT at Rs. 14.64 Cr

Krsnaa Diagnostics has reported total income of Rs. 143.80 crores during the period ended June 30, 2023

News
News | 13 August 2023

Panacea Biotec posts Q1 FY24 consolidated PAT at Rs. 10.98 Cr

Panacea Biotec has reported total income of Rs. 135.27 crores during the period ended June 30, 2023

News
News | 13 August 2023

LyondellBasell awarded the 2023 Global Medical Plastics Company of the year

LyondellBasell is among the top three global polyolefin manufacturers in terms of capacity and sustainable solutions

News
News | 13 August 2023

WuXi XDC and Boostimmune sign MoU for integrated services

Boostimmune will have access to WuXi XDC's fully integrated one-stop bioconjugate platform

News
News | 12 August 2023

Gujarat Themis Biosyn posts Q1 FY24 PAT at Rs. 17.72 Cr

Gujarat Themis Biosyn has reported total income of Rs. 50.66 crores during the period ended June 30, 2023

News
News | 12 August 2023

IPCA Laboratories posts Q1 FY24 consolidated PAT at Rs. 162.82 Cr

IPCA Laboratories has reported total income of Rs. 1632.43 crores during the period ended June 30, 2023

Startup

Digitization